Karly P. Garnock-Jones

3.5k total citations
79 papers, 2.2k citations indexed

About

Karly P. Garnock-Jones is a scholar working on Surgery, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Karly P. Garnock-Jones has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Pathology and Forensic Medicine and 11 papers in Molecular Biology. Recurrent topics in Karly P. Garnock-Jones's work include Autoimmune Bullous Skin Diseases (6 papers), Treatment of Major Depression (6 papers) and Gastroesophageal reflux and treatments (5 papers). Karly P. Garnock-Jones is often cited by papers focused on Autoimmune Bullous Skin Diseases (6 papers), Treatment of Major Depression (6 papers) and Gastroesophageal reflux and treatments (5 papers). Karly P. Garnock-Jones collaborates with scholars based in New Zealand, Germany and United States. Karly P. Garnock-Jones's co-authors include Gillian M. Keating, Lesley J. Scott, Susan J. Keam, Sarah L. Greig, Paul L. McCormack, Monique P Curran, Sohita Dhillon, Esther Kim, Greg L. Plosker and Anna R. Giuliano and has published in prestigious journals such as Drugs, CNS Drugs and Drugs & Aging.

In The Last Decade

Karly P. Garnock-Jones

76 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karly P. Garnock-Jones New Zealand	26	668	292	273	269	198	79	2.2k
Nishit B. Modi United States	29	531 0.8×	168 0.6×	316 1.2×	632 2.3×	159 0.8×	91	2.7k
Thomas Mohr Austria	35	1.3k 1.9×	452 1.5×	353 1.3×	291 1.1×	212 1.1×	129	3.7k
Yvette N. Lamb New Zealand	28	954 1.4×	483 1.7×	213 0.8×	146 0.5×	79 0.4×	63	2.8k
Yukio Kimura Japan	28	601 0.9×	130 0.4×	476 1.7×	545 2.0×	156 0.8×	191	2.9k
Hannah A. Blair New Zealand	34	928 1.4×	539 1.8×	274 1.0×	97 0.4×	127 0.6×	138	3.3k
Aiping Zhang China	24	503 0.8×	220 0.8×	260 1.0×	114 0.4×	90 0.5×	101	1.8k
Kenji Matsumoto Japan	22	612 0.9×	173 0.6×	306 1.1×	71 0.3×	85 0.4×	153	2.3k
Masayuki Niwa Japan	33	1.7k 2.5×	300 1.0×	335 1.2×	119 0.4×	307 1.6×	197	3.8k
Jean‐Paul Boissel France	24	780 1.2×	198 0.7×	138 0.5×	359 1.3×	106 0.5×	55	2.6k
Yeong‐Hau H. Lien United States	32	953 1.4×	200 0.7×	345 1.3×	131 0.5×	95 0.5×	85	3.1k

Countries citing papers authored by Karly P. Garnock-Jones

Since Specialization

Citations

This map shows the geographic impact of Karly P. Garnock-Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karly P. Garnock-Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karly P. Garnock-Jones more than expected).

Fields of papers citing papers by Karly P. Garnock-Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karly P. Garnock-Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karly P. Garnock-Jones. The network helps show where Karly P. Garnock-Jones may publish in the future.

Co-authorship network of co-authors of Karly P. Garnock-Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Karly P. Garnock-Jones. A scholar is included among the top collaborators of Karly P. Garnock-Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karly P. Garnock-Jones. Karly P. Garnock-Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garnock-Jones, Karly P. & Sean T. Duggan. (2017). Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids. Drugs. 77(15). 1665–1675. 12 indexed citations

Al-Salama, Zaina T., Karly P. Garnock-Jones, & Lesley J. Scott. (2017). Ixazomib: A Review in Relapsed and/or Refractory Multiple Myeloma. Targeted Oncology. 12(4). 535–542. 18 indexed citations

Burness, Celeste B., Gillian M. Keating, & Karly P. Garnock-Jones. (2016). Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia. Drugs. 76(8). 869–878. 25 indexed citations

Garnock-Jones, Karly P.. (2016). Brexpiprazole: A Review in Schizophrenia. CNS Drugs. 30(4). 335–342. 19 indexed citations

Garnock-Jones, Karly P. & Katherine A. Lyseng‐Williamson. (2015). Vortioxetine in major depressive disorder: a guide to its use in the EU. Drugs & Therapy Perspectives. 31(7). 221–228.

Garnock-Jones, Karly P.. (2014). Diclofenac Potassium Powder for Oral Solution: A Review of Its Use in Patients with Acute Migraine. CNS Drugs. 28(8). 761–768. 5 indexed citations

Garnock-Jones, Karly P.. (2014). Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease. BioDrugs. 29(1). 57–67. 12 indexed citations

Hair, Philip I, Fiona Cameron, & Karly P. Garnock-Jones. (2013). Levomilnacipran Extended Release: First Global Approval. Drugs. 73(14). 1639–1645. 7 indexed citations

Garnock-Jones, Karly P.. (2013). Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy. American Journal of Cardiovascular Drugs. 13(2). 141–150. 3 indexed citations

10.

Garnock-Jones, Karly P.. (2012). Azithromycin 1.5% Ophthalmic Solution. Drugs. 72(3). 361–373. 18 indexed citations

11.

Garnock-Jones, Karly P.. (2012). Glycopyrrolate Oral Solution. Pediatric Drugs. 14(4). 263–269. 31 indexed citations

12.

Scott, Lesley J., Katherine A. Lyseng‐Williamson, & Karly P. Garnock-Jones. (2012). Oromucosal Midazolam: A Guide to Its Use in Paediatric Patients with Prolonged Acute Convulsive Seizures. CNS Drugs. 26(10). 893–897. 7 indexed citations

13.

Garnock-Jones, Karly P.. (2011). Nilotinib. Drugs. 71(12). 1579–1590. 8 indexed citations

14.

Garnock-Jones, Karly P.. (2011). Dextromethorphan/Quinidine. CNS Drugs. 25(5). 435–445. 19 indexed citations

15.

Garnock-Jones, Karly P., Gillian M. Keating, & Lesley J. Scott. (2010). Trastuzumab. Drugs. 70(2). 215–239. 79 indexed citations

16.

Garnock-Jones, Karly P. & Paul L. McCormack. (2010). Escitalopram. CNS Drugs. 24(9). 769–796. 50 indexed citations

17.

Garnock-Jones, Karly P.. (2010). Ecallantide. Drugs. 70(11). 1423–1431. 18 indexed citations

18.

Garnock-Jones, Karly P. & Gillian M. Keating. (2009). Atomoxetine. Pediatric Drugs. 11(3). 203–226. 158 indexed citations

19.

Garnock-Jones, Karly P. & Gillian M. Keating. (2009). Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†. CNS Drugs. 24(1). 85–88. 24 indexed citations

20.

Garnock-Jones, Karly P., Sohita Dhillon, & Lesley J. Scott. (2009). Armodafinil. CNS Drugs. 23(9). 793–803. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact